Buildit, Thank you for clarifying the point I was
Post# of 36537
(Total Views: 304)
Posted On: 10/28/2020 3:32:56 PM
Buildit,
Thank you for clarifying the point I was trying to make. Yes, continuing good news is important, like what has been made public in October. Think of it as a space launce countdown check list. All the things needed for a successful NGIO launched have been listed and are now being checked off. While the other vaccines are struggling to achieve altitude, imagine the NGIO IPO date announced with the news of FDA trial approval and because of the Ii-key technology, Phase 1 safety protocols have been met and NGIO is proceeding to Phase 2. Plus the list of all the other countries lining up for the NGIO vaccine. Investors went “nuts” over a pharmaceutical just saying they were going to start a trial. So while many of the news items have been for a smaller target audience, we cannot be sure how much “word of mouth” about NGIO has been spread. Even though there are about a dozen regular posters on this board, there are close to 200 views depending on the post. Who are these readers and who are the telling about NGIO and GNBT? I don’t think we really know how many people are sitting on the sideline just waiting for the right moment to get into the game.
Thank you for clarifying the point I was trying to make. Yes, continuing good news is important, like what has been made public in October. Think of it as a space launce countdown check list. All the things needed for a successful NGIO launched have been listed and are now being checked off. While the other vaccines are struggling to achieve altitude, imagine the NGIO IPO date announced with the news of FDA trial approval and because of the Ii-key technology, Phase 1 safety protocols have been met and NGIO is proceeding to Phase 2. Plus the list of all the other countries lining up for the NGIO vaccine. Investors went “nuts” over a pharmaceutical just saying they were going to start a trial. So while many of the news items have been for a smaller target audience, we cannot be sure how much “word of mouth” about NGIO has been spread. Even though there are about a dozen regular posters on this board, there are close to 200 views depending on the post. Who are these readers and who are the telling about NGIO and GNBT? I don’t think we really know how many people are sitting on the sideline just waiting for the right moment to get into the game.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼